{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:40:19Z","timestamp":1777524019133,"version":"3.51.4"},"reference-count":24,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2556,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1111\/j.1529-8019.2008.00227.x","type":"journal-article","created":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T18:07:26Z","timestamp":1222884446000},"page":"S15-S20","source":"Crossref","is-referenced-by-count":1,"special_numbering":"supplement","title":["Adalimumab for treatment of moderate to severe psoriasis and psoriatic arthritis"],"prefix":"10.1155","volume":"21","author":[{"given":"M. R.","family":"Bongiorno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Pistone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Doukaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Aric\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00015550252948130","article-title":"Quality of life and prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations: data from the Nordic Quality of Life Study","volume":"82","author":"Zachariae","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"Suppl. 2","key":"10.1111\/j.1529-8019.2008.00227.x-BIB2","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB3","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1517\/13543784.9.7.1511","article-title":"Psoriatic arthritis","volume":"9","author":"Gladman","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB4","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinic and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/rheumatology\/23.4.246","article-title":"Psoriatic arthritis in psoriatic patients","volume":"23","author":"Scarpa","year":"1984","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB6","first-page":"69","article-title":"Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report","volume":"146","author":"Biondi Oriente","year":"1989","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/rheumatology\/kel214","article-title":"The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis: a high-resolution MRI and histology study","volume":"46","author":"Tan","year":"2007","journal-title":"Rheumatology"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/rheumatology\/33.9.834","article-title":"Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease","volume":"33","author":"Jones","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14712598.2.4.431","article-title":"Selective targeting of T cell subsets: focus on alefacept\u00a0-\u00a0a remittive therapy for psoriasis","volume":"2","author":"Krueger","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s002960050028","article-title":"Inflammatory infiltrate and interleukin-8 expression in the synovium of psoriatic arthritis\u00a0-\u00a0an immunohistochemical and mRNA analysis","volume":"17","author":"K\u00f6nig","year":"1997","journal-title":"Rheumatol Int"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB12","first-page":"1117","article-title":"Predominance of CD8+ T lymphocytes in psoriatic arthritis","volume":"26","author":"Costello","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00510050","article-title":"Immunocompetent cells in psoriasis: in situ immunophenotyping by monoclonal antibodies","volume":"275","author":"Bos","year":"1983","journal-title":"Arch Dermatol Res"},{"issue":"2 Suppl. 4","key":"10.1111\/j.1529-8019.2008.00227.x-BIB14","first-page":"16","article-title":"Mechanisms of tumor necrosis factor action","volume":"19","author":"Sc\u00fct\u00fcze","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB15","first-page":"393","article-title":"Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis","volume":"37","author":"Ritchie","year":"1968","journal-title":"Q J Med"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/1523-1747.ep12371679","article-title":"The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response","volume":"101","author":"Uyemura","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2249.1994.tb06244.x","article-title":"Elevated tumour necrosis factor-\u03b1 (TNF-\u03b1) biological activity in psoriatic skin lesions","volume":"96","author":"Ettehadi","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB18","first-page":"518","article-title":"Highly increased levels of tumor necrosis factor \u03b1 and other proinflammatory cytokines in psoriatic arthritis synovial fluid","volume":"24","author":"Partsch","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00003246-199902000-00038","article-title":"Differential expression of tumor necrosis factor receptor subtypes on leukocytes in systemic inflammatory response syndrome","volume":"27","author":"H\u00fcbl","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/cyto.1996.0011","article-title":"Expression of cytokines and their receptors by psoriatic fibroblasts, II. Decreased TNF receptor expression","volume":"8","author":"Debets","year":"1996","journal-title":"Cytokine"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.164.2.656","article-title":"The p55 TNF-\u03b1 receptor plays a critical role in T cell alloreactivity","volume":"164","author":"Hill","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB22","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4049\/jimmunol.160.2.943","article-title":"TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation","volume":"160","author":"Peschon","year":"1998","journal-title":"J Immunol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1365-2133.2005.06582.x","article-title":"Extensive plaque psoriasis successfully treated with adalimumab (Humira)","volume":"152","author":"Sladden","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2008.00227.x-BIB24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2005.06759.x","article-title":"Successful treatment of recalcitrant acrodermatitis continua of Hallopeau with adalimumab and acitretin","volume":"153","author":"Tobin","year":"2005","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2008.00227.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2008.00227.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:10:53Z","timestamp":1738404653000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2008.00227.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2008.00227.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}